47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.20.Z - Rental and management of own or leased real estate
73.1 - Advertising
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 10,5 | 11,6 | 10 | -13,9 |
EBITDA | 10,7 | 11,8 | 10,3 | -13,2 |
Short time liabilities | 29,9 | 34,6 | 36,6 | 5,9 |
Equity capital | 4,1 | -1,9 | 1,1 | 158,8 |
Operating profit (EBIT) | 10,5 | 11,6 | 10,1 | -13,4 |
Assets | 34,7 | 33,4 | 38,9 | 16,4 |
Net profit (loss) | 10,5 | 11,6 | 10 | -13,9 |
Cash | 10,3 | 4,6 | 4 | -11,5 |
Liabilities and provisions for liabilities | 30,6 | 35,3 | 37,8 | 6,9 |
Net income from sale | 207,6 | 249,5 | 282,1 | 13,1 |
Working assets | 33,9 | 32,8 | 38 | 16,1 |
Depreciation | 0,3 | 0,2 | 0,2 | 2,5 |
% | % | % | p.p. | |
Profitability of capital | 252,1 | -610,8 | 893,7 | 1504,5 |
Equity capital to total assets | 11,9 | -5,7 | 2,9 | 8,6 |
Gross profit margin | 5 | 4,7 | 3,5 | -1,2 |
EBITDA Margin | 5,2 | 4,7 | 3,6 | -1,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 52 | 51 | 47 | -4 |
Current financial liquidity indicator | 1.110100507736206 | 0.927471399307251 | 1.006761074066162 | 0,1 |
Net dept to EBITDA | -0.9581546187400818 | -0.3862301707267761 | -0.39366698265075684 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane